SurgePays (SURG) had the highest return between January 8, 2018 and February 25, 2018 by a US stock, returning 3,109.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
SurgePays (SURG) | 1/8/2018 - 2/25/2018 | 3,109.88% |
Quantum Computing (QUBT) | 1/8/2018 - 2/25/2018 | 2,400% |
TONX (TONX) | 1/8/2018 - 2/25/2018 | 430.97% |
TNF Pharmaceuticals (TNFA) | 1/8/2018 - 2/25/2018 | 237.57% |
Fubotv (FUBO) | 1/8/2018 - 2/25/2018 | 157.14% |
Atara Biotherapeutics (ATRA) | 1/8/2018 - 2/25/2018 | 137.2% |
Iovance Biotherapeutics (IOVA) | 1/8/2018 - 2/25/2018 | 128.92% |
POET Technologies (POET) | 1/8/2018 - 2/25/2018 | 127.78% |
Atossa Genetics (ATOS) | 1/8/2018 - 2/25/2018 | 122.96% |
Nutriband (NTRB) | 1/8/2018 - 2/25/2018 | 121.56% |
Newegg Commerce (NEGG) | 1/8/2018 - 2/25/2018 | 107.51% |
Kaival Brands Innovations (KAVL) | 1/8/2018 - 2/25/2018 | 100% |
Eastman Kodak (KODK) | 1/8/2018 - 2/25/2018 | 98.41% |
Data Storage (DTST) | 1/8/2018 - 2/25/2018 | 90.9% |
NuCana (NCNA) | 1/8/2018 - 2/25/2018 | 87.21% |
Crispr Therapeutics (CRSP) | 1/8/2018 - 2/25/2018 | 80.84% |
Immuron Ltd ADR (IMRN) | 1/8/2018 - 2/25/2018 | 80.63% |
Netcapital (NCPL) | 1/8/2018 - 2/25/2018 | 80% |
Novavax (NVAX) | 1/8/2018 - 2/25/2018 | 79.23% |
InnovAge (INNV) | 1/8/2018 - 2/25/2018 | 76.97% |
Kazia Therapeutics Ltd ADR (KZIA) | 1/8/2018 - 2/25/2018 | 73.13% |
Gyre Therapeutics (GYRE) | 1/8/2018 - 2/25/2018 | 72.49% |
Fate Therapeutics (FATE) | 1/8/2018 - 2/25/2018 | 71.68% |
Vyne Therapeutics (VYNE) | 1/8/2018 - 2/25/2018 | 69.41% |
Nutex Health (NUTX) | 1/8/2018 - 2/25/2018 | 67.66% |
